Nuclear Medicine and Biology
Volume 37, Issue 8 , Pages 1005-1012 , November 2010

Myocardial 99mTc-sestamibi extraction and washout in hypertensive heart failure using an isolated rat heart

  • Kenji Fukushima

      Affiliations

    • Department of Cardiology, Tokyo Women's Medical University, Tokyo 162-8666, Japan
    • Department of Radiology, Johns Hopkins University, Baltimore, MD, USA
    • ,
  • Mitsuru Momose

      Affiliations

    • Department of Diagnostic Imaging and Nuclear Medicine, Tokyo Women's Medical University, Tokyo 162-8666, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 3 3353 8111; fax: +81 3 5269 7531.
    • ,
  • Chisato Kondo

      Affiliations

    • Department of Diagnostic Imaging and Nuclear Medicine, Tokyo Women's Medical University, Tokyo 162-8666, Japan
    • ,
  • Takahiro Higuchi

      Affiliations

    • Department of Radiology, Johns Hopkins University, Baltimore, MD, USA
    • ,
  • Kiyoko Kusakabe

      Affiliations

    • Department of Diagnostic Imaging and Nuclear Medicine, Tokyo Women's Medical University, Tokyo 162-8666, Japan
    • ,
  • Nobuhisa Hagiwara

      Affiliations

    • Department of Cardiology, Tokyo Women's Medical University, Tokyo 162-8666, Japan

Received 27 January 2010 ,Revised 3 June 2010 ,Accepted 3 July 2010.

References 

  1. Larson LW, Gerbert DA, Herman LM, Leger MM, McNellis R, O'Donoghue DL, et al. ACC/AHA 2005 guideline update: chronic heart failure in the adult. Jaapa. 2006;19:53–56
  2. Uddin N, Patterson JH. Current guidelines for treatment of heart failure: 2006 update. Pharmacotherapy. 2007;27:12S–17S
  3. Viganego F, Le Jemtel TH. Progression and management of chronic heart failure. Panminerva Med. 2007;49:109–118
  4. Rapp JP, Dene H. Development and characteristics of inbred strains of Dahl salt-sensitive and salt-resistant rats. Hypertension. 1985;7:340–349
  5. Terry AV, Hernandez CM, Buccafusco JJ. Dahl salt-sensitive and salt-resistant rats: examination of learning and memory performance, blood pressure, and the expression of central nicotinic acetylcholine receptors. Neuroscience. 2001;103:351–363
  6. Doi R, Masuyama T, Yamamoto K, Doi Y, Mano T, Sakata Y, et al. Development of different phenotypes of hypertensive heart failure: systolic versus diastolic failure in Dahl salt-sensitive rats. J Hypertens. 2000;18:111–120
  7. Inoko M, Kihara Y, Morii I, Fujiwara H, Sasayama S. Transition from compensatory hypertrophy to dilated, failing left ventricles in Dahl salt-sensitive rats. Am J Physiol. 1994;267:H2471–2482
  8. Kihara Y, Sasayama S. Transition from compensatory hypertrophy to dilated failing left ventricle in Dahl-Iwai salt-sensitive rats. Am J Hypertens. 1997;10:78S–82S
  9. Ono K, Masuyama T, Yamamoto K, Doi R, Sakata Y, Nishikawa N, et al. Echo Doppler assessment of left ventricular function in rats with hypertensive hypertrophy. J Am Soc Echocardiogr. 2002;15:109–117
  10. Tsutsui H, Kinugawa S, Matsushima S. Mitochondrial oxidative stress and dysfunction in myocardial remodelling. Cardiovasc Res. 2009;81:449–456
  11. Berman DS, Kiat H, Van Train K, Garcia E, Friedman J, Maddahi J. Technetium 99 m sestamibi in the assessment of chronic coronary artery disease. Semin Nucl Med. 1991;21:190-
  12. Maddahi J, Kiat H, Van Train KF, Prigent F, Friedman J, Garcia EV, et al. Myocardial perfusion imaging with technetium-99 m sestamibi SPECT in the evaluation of coronary artery disease. Am J Cardiol. 1990;66:55E–62E
  13. Arbab AS, Koizumi K, Toyama K, Arai T, Araki T. Technetium-99 m-tetrofosmin, technetium-99 m-MIBI and thallium-201 uptake in rat myocardial cells. J Nucl Med. 1998;39:266–271
  14. Carvalho PA, Chiu ML, Kronauge JF, Kawamura M, Jones AG, Holman BL, et al. Subcellular distribution and analysis of technetium-99 m-MIBI in isolated perfused rat hearts. J Nucl Med. 1992;33:1516–1522
  15. McGoron AJ, Gerson MC, Biniakiewicz DS, Roszell NJ, Washburn LC, Millard RW. Extraction and retention of technetium-99 m Q12, technetium-99 m sestamibi, and thallium-201 in isolated rat heart during coronary acidemia. Eur J Nucl Med. 1997;24:1479–1486
  16. Meerdink DJ, Leppo JA. Experimental studies of the physiologic properties of technetium-99 m agents: myocardial transport of perfusion imaging agents. Am J Cardiol. 1990;66:9E–15E
  17. Liu Z, Johnson G, Beju D, Okada RD. Detection of myocardial viability in ischemic-reperfused rat hearts by Tc-99 m sestamibi kinetics. J Nucl Cardiol. 2001;8:677–686
  18. Matsuo S, Nakae I, Tsutamoto T, Okamoto N, Horie M. A novel clinical indicator using Tc-99 m sestamibi for evaluating cardiac mitochondrial function in patients with cardiomyopathies. J Nucl Cardiol. 2007;14:215–220
  19. Unno K, Isobe S, Izawa H, Cheng XW, Kobayashi M, Hirashiki A, et al. Relation of functional and morphological changes in mitochondria to myocardial contractile and relaxation reserves in asymptomatic to mildly symptomatic patients with hypertrophic cardiomyopathy. Eur Heart J. 2009;30:1853–1862
  20. Klotz S, Hay I, Zhang G, Maurer M, Wang J, Burkhoff D. Development of heart failure in chronic hypertensive Dahl rats: focus on heart failure with preserved ejection fraction. Hypertension. 2006;47:901–911
  21. Fukushima K, Momose M, Kondo C, Kusakabe K, Kasanuki H. Myocardial kinetics of (201)Thallium, (99 m)Tc-tetrofosmin, and (99 m)Tc-sestamibi in an acute ischemia-reperfusion model using isolated rat heart. Ann Nucl Med. 2007;21:267–273
  22. Ikeda S, Hamada M, Qu P, Hiasa G, Hashida H, Shigematsu Y, et al. Relationship between cardiomyocyte cell death and cardiac function during hypertensive cardiac remodelling in Dahl rats. Clin Sci (Lond). 2002;102:329–335
  23. Louhelainen M, Vahtola E, Kaheinen P, Leskinen H, Merasto S, Kyto V, et al. Effects of levosimendan on cardiac remodeling and cardiomyocyte apoptosis in hypertensive Dahl/Rapp rats. Br J Pharmacol. 2007;150:851–861
  24. Brown L, Fenning A, Chan V, Loch D, Wilson K, Anderson B, et al. Echocardiographic assessment of cardiac structure and function in rats. Heart Lung Circ. 2002;11:167–173
  25. de Simone G, Wallerson DC, Volpe M, Devereux RB. Echocardiographic measurement of left ventricular mass and volume in normotensive and hypertensive rats. Necropsy validation. Am J Hypertens. 1990;3:688–696
  26. Okruhlicova L, Tribulova N, Weismann P, Sotnikova R. Ultrastructure and histochemistry of rat myocardial capillary endothelial cells in response to diabetes and hypertension. Cell Res. 2005;15:532–538
  27. Lesnefsky EJ, Moghaddas S, Tandler B, Kerner J, Hoppel CL. Mitochondrial dysfunction in cardiac disease: ischemia–reperfusion, aging, and heart failure. J Mol Cell Cardiol. 2001;33:1065–1089
  28. Suleiman MS, Halestrap AP, Griffiths EJ. Mitochondria: a target for myocardial protection. Pharmacol Ther. 2001;89:29–46
  29. Beanlands RS, Dawood F, Wen WH, McLaughlin PR, Butany J, D'Amati G, et al. Are the kinetics of technetium-99 m methoxyisobutyl isonitrile affected by cell metabolism and viability?. Circulation. 1990;82:1802–1814
  30. Tsujimoto Y, Shimizu S. Role of the mitochondrial membrane permeability transition in cell death. Apoptosis. 2007;12:835–840
  31. Okada RD, Glover DK, Nguyen KN, Johnson G. Technetium-99 m sestamibi kinetics in reperfused canine myocardium. Eur J Nucl Med. 1995;22:600–607
  32. Stanley WC, Hoppel CL. Mitochondrial dysfunction in heart failure: potential for therapeutic interventions?. Cardiovasc Res. 2000;45:805–806
  33. Weiss JN, Korge P, Honda HM, Ping P. Role of the mitochondrial permeability transition in myocardial disease. Circ Res. 2003;93:292–301
  34. Kong SW, Bodyak N, Yue P, Liu Z, Brown J, Izumo S, et al. Genetic expression profiles during physiological and pathological cardiac hypertrophy and heart failure in rats. Physiol Genomics. 2005;21:34–42
  35. Saraste A, Pulkki K. Morphologic and biochemical hallmarks of apoptosis. Cardiovasc Res. 2000;45:528–537
  36. Saraste A, Pulkki K, Kallajoki M, Heikkila P, Laine P, Mattila S, et al. Cardiomyocyte apoptosis and progression of heart failure to transplantation. Eur J Clin Invest. 1999;29:380–386
  37. Saraste A, Voipio-Pulkki LM, Parvinen M, Pulkki K. Apoptosis in the heart. N Engl J Med. 1997;336:1025–1026[author reply 6]
  38. Kang PM, Izumo S. Apoptosis and heart failure: A critical review of the literature. Circ Res. 2000;86:1107–1113
  39. Okada H, Takemura G, Koda M, Kanoh M, Kawase Y, Minatoguchi S, et al. Myocardial apoptotic index based on in situ DNA nick end-labeling of endomyocardial biopsies does not predict prognosis of dilated cardiomyopathy. Chest. 2005;128:1060–1062

☆ Statement: We have no financial relationship, and have full control of all primary data. We agree to allow the reviewer to review our data if requested.

PII: S0969-8051(10)00321-5

doi: 10.1016/j.nucmedbio.2010.07.002

Nuclear Medicine and Biology
Volume 37, Issue 8 , Pages 1005-1012 , November 2010

Article Tools

* Image Usage & Resolution